Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Foghorn Therapeutics Inc. | 50,000 | reported | 01 May 2025 | tx 1+50,000 |
| Milestone Pharmaceuticals Inc. | 40,000 | reported | 10 Jun 2025 | tx 3+80,000−80,000 |
| EyePoint, Inc. | 40,000 | reported | 02 Jan 2026 | tx 4+165,014 |
| ACHIEVE LIFE SCIENCES, INC. | 31,500 | reported | 06 Jun 2025 | tx 4+110,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | EyePoint, Inc. | 40,000 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 40,000 | 0.00 USD | deriv |
| 06 Jun 2025 | GRANT_AWARD | ACHIEVE LIFE SCIENCES, INC. | 31,500 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | Foghorn Therapeutics Inc. | 50,000 | 4.16 USD | deriv |
| 03 Jan 2025 | GRANT_AWARD | EyePoint, Inc. | 40,000 | 0.00 USD | deriv |
| 28 Aug 2024 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 40,000 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 80,000 | 0.00 USD | deriv |
| 22 Jan 2024 | GRANT_AWARD | ACHIEVE LIFE SCIENCES, INC. | 31,500 | 0.00 USD | deriv |
| 05 Jan 2024 | GRANT_AWARD | EyePoint, Inc. | 25,014 | 0.00 USD | deriv |
| 16 Oct 2023 | GRANT_AWARD | EyePoint, Inc. | 60,000 | 0.00 USD | deriv |
| 29 Mar 2023 | GRANT_AWARD | ACHIEVE LIFE SCIENCES, INC. | 23,250 | 0.00 USD | deriv |
| 29 Mar 2023 | GRANT_AWARD | ACHIEVE LIFE SCIENCES, INC. | 24,000 | 0.00 USD | deriv |